Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
News Briefing channel feed
Novo, Ascendis to work on monthly GLP-1; KalVista makes a royalty deal
6 months ago
FDA removes hold on three CARsgen CAR-T trials; Ono passes on itolizumab
6 months ago
Boehringer, Gubra stop work on obesity drug; Galapagos restarts CAR-T study
6 months ago
Leal Therapeutics raises $45M; SynOx adds to Series B
6 months ago
Vera’s $300M offering; Abeona resubmits treatment for rare skin disease
6 months ago
Biogen's full Ph2 data for IgA nephropathy drug; Sanofi invests in obesity biotech
6 months ago
EnGene’s $60M PIPE; AbbVie to develop neuropsychiatric drugs with Gedeon Richter
7 months ago
Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans
7 months ago
Eccogene gets $60M from AstraZeneca; Evotec also records milestone with BMS
7 months ago
MacroGenics sells rights to breast cancer drug; Rice’s new biotech accelerator
7 months ago
GSK to put £50M into Cambridge University partnership; Angelini’s new deal
7 months ago
Aura’s bladder cancer data; Poseida discloses $15M milestone from Roche
7 months ago
Viatris, Lexicon ink licensing deal; Capricor’s $75M offering
7 months ago
Exscientia’s $15M milestone from Sanofi; Lilly to take Gateway Labs to China
7 months ago
Cycle makes another offer for Vanda; Ocean Biomedical, Molecure ink new deal
7 months ago
Akeso raises $250M; SalioGen’s layoffs
7 months ago
Ono’s ADC deal; Leo Pharma to conduct layoffs
7 months ago
Crinetics’ $500M offering; Boehringer inks deal with macrocycles biotech
7 months ago
Scholar Rock aims to raise $275M; Vincerx to reshuffle pipeline focus
7 months ago
Galapagos investor gets board seat; OnKure completes merger with Reneo
7 months ago
Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech
7 months ago
FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea
7 months ago
Biohaven aims to raise $250M; Activist investor's stake in Galapagos exceeds 10%
7 months ago
CSPC, Alphamab Oncology make an ADC deal; Visen’s IPO in Hong Kong
7 months ago
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page